Medical and Science
The Gut-Brain connection

For centuries, treating neurological conditions meant developing therapies or drugs that directly targeted the brain. Today the evidence argues that research, drugs, and therapy should actually focus on the gut.
The gut and brain have a unique connection that allows for communication past the brain’s main line of defense – the blood brain barrier. Many molecules that cross over the blood brain barrier are created by the gut microbiome, meaning that the brain and gut directly influence one another.
Watch the fascinating video to learn how the gut-brain pathway may lead us to discover causes behind, and even treatments for, life-altering conditions like Autism Spectrum Disorder and Parkinson’s Disease. By understanding communication between the gut and the brain, we may be able to change the course of neurological disease for generations.
About Sarkis Mazmanian
Medical microbiologist Sarkis K. Mazmanian is leading research into how the gut microbiome impacts and communicates with the immune and nervous systems. His work is specifically focused on how this two-way internal communication highway, known as the “gut-brain axis,” influences complex diseases of the brain, such as Parkinson’s and Alzheimer’s diseases. Sarkis has received numerous awards including the MacArthur Foundation “Genius” award and Discover Magazine’s “Best Brains in Science.” Currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering at the California Institute of Technology, Sarkis is also a founder of two biotech companies and the proud mentor of countless students and postdoctoral fellows who have gone on to successful independent careers in medicine, industry, and academia.
You may also like Australian researchers reveal new insights into retina’s genetic code
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More